Table of Content

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKETS COVERED 18
1.4 YEARS CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 19
1.6 LIMITATIONS 19
1.7 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.2 MARKET SIZE ESTIMATION 24
2.3 DATA TRIANGULATION 26
2.3.1 ASSUMPTIONS FOR THE STUDY 27
2.3.2 LIMITATIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 31
4.1 PROTEIN ENGINEERING MARKET OVERVIEW 31
4.2 ASIA PACIFIC: PROTEIN ENGINEERING MARKET, BY PRODUCT (2018) 32
4.3 PROTEIN ENGINEERING MARKET, BY END USER (2018) 33
4.4 PROTEIN ENGINEERING MARKET, BY REGION (2018) 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 34
5.2.1.1 Increasing investments in synthetic biology 34
5.2.1.2 Growing focus on protein-based drug development by pharmaceutical & biotechnology firms 35
5.2.2 RESTRAINTS 35
5.2.2.1 High cost of instruments 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Emerging markets 36

6 PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 37
6.1 INTRODUCTION 38
6.2 INSTRUMENTS 38
6.2.1 INSTRUMENTS WILL CONTINUE TO DOMINATE THE PROTEIN ENGINEERING MARKET IN THE FORECAST PERIOD 38
6.3 CONSUMABLES 40
6.3.1 INCREASING DEMAND FOR CONSUMABLES IN PROTEOMICS RESEARCH IS SUPPORTING MARKET GROWTH 40
6.4 SOFTWARE & SERVICES 41
6.4.1 SOFTWARE & SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH BETWEEN 2019 AND 2024 41

7 PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 43
7.1 INTRODUCTION 44
7.2 MONOCLONAL ANTIBODIES 44
7.2.1 ACCURATE BINDING CAPACITY AND SPECIFICITY HAVE SUPPORTED
THE USE OF MABS 44
7.3 INSULIN 46
7.3.1 INCREASING BURDEN OF DIABETES HAS DRIVEN THE DEMAND FOR INSULIN 46
7.4 ERYTHROPOIETINS 47
7.4.1 CONTINUOUS RESEARCH AND FUNDING TO PROMOTE THE GROWTH OF ERYTHROPOIETINS 47
7.5 INTERFERONS 49
7.5.1 RISING ANEMIA INCIDENCE IS A KEY DRIVER OF THE MARKET FOR INTERFERONS 49
7.6 VACCINES 50
7.6.1 HIGH INCIDENCE OF DISEASES SUCH AS HEPATITIS AND INFLUENZA LIKELY TO BOOST MARKET GROWTH 50
7.7 COLONY-STIMULATING FACTORS 52
7.7.1 DEMAND FOR CSF IN BONE AND INFLAMMATION TREATMENT LIKELY TO BOOST THE MARKET 52
7.8 GROWTH HORMONES 53
7.8.1 DEMAND FOR HORMONE THERAPIES LIKELY TO BOOST THE MARKET 53
7.9 COAGULATION FACTORS 55
7.9.1 THE NEED TO COMBAT HEMOPHILIA IS EXPECTED TO BE THE PRIMARY GROWTH DRIVER FOR THIS MARKET SEGMENT 55
7.10 OTHER PROTEINS 56

8 PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 58
8.1 INTRODUCTION 59
8.2 RATIONAL PROTEIN DESIGN 59
8.2.1 ADVANCEMENTS IN BIOINFORMATICS TOOLS TO PROPEL MARKET GROWTH 59
?
8.3 IRRATIONAL PROTEIN DESIGN/DIRECTED EVOLUTION 61
8.3.1 THIS PROCESS INVOLVES A NUMBER OF UNCERTAINTIES, WHICH MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT 61

9 PROTEIN ENGINEERING MARKET, BY END USER 63
9.1 INTRODUCTION 64
9.2 BIOPHARMACEUTICAL COMPANIES 64
9.2.1 BIOPHARMACEUTICAL COMPANIES DOMINATE THE PROTEIN ENGINEERING MARKET 64
9.3 CONTRACT RESEARCH ORGANIZATIONS 66
9.3.1 INCREASING NEED FOR OUTSOURCING PROTEIN ENGINEERING ACTIVITIES TO CROS TO SUPPORT MARKET GROWTH 66
9.4 ACADEMIC RESEARCH INSTITUTES 67
9.4.1 NEED FOR NOVEL PROTEINS FOR THE PRODUCTION OF BIOTHERAPEUTICS TO BOOST MARKET GROWTH 67

10 PROTEIN ENGINEERING MARKET, BY REGION 70
10.1 INTRODUCTION 71
10.2 NORTH AMERICA 72
10.2.1 US 74
10.2.1.1 Patent expiry and increasing research funds 74
10.2.2 CANADA 76
10.2.2.1 R&D activities in research institutes and universities to drive market growth 76
10.3 EUROPE 78
10.3.1 GERMANY 79
10.3.1.1 Strong R&D base and presence of research centers to drive market growth 79
10.3.2 UK 81
10.3.2.1 Strong preclinical pipeline to support market growth 81
10.3.3 FRANCE 83
10.3.3.1 Conference and events in France likely to create awareness 83
10.3.4 REST OF EUROPE 84
10.4 ASIA PACIFIC 86
10.4.1 JAPAN 88
10.4.1.1 Government initiatives in genomics and proteomics are likely to support market growth in Japan 88
10.4.2 CHINA 90
10.4.2.1 Presence of a favorable funding scenario and collaborations will drive market growth 90
10.4.3 INDIA 92
10.4.3.1 Government initiatives will propel market growth in India 92
10.4.4 REST OF ASIA PACIFIC 93
10.5 REST OF THE WORLD 95

11 COMPETITIVE LANDSCAPE 97
11.1 INTRODUCTION 97
11.2 MARKET RANK ANALYSIS, 2018 97
11.3 COMPETITIVE LEADERSHIP MAPPING (2019) 98
11.3.1 VENDOR INCLUSION CRITERIA 98
11.3.2 VISIONARY LEADERS 98
11.3.3 INNOVATORS 98
11.3.4 DYNAMIC DIFFERENTIATORS 98
11.3.5 EMERGING COMPANIES 98
11.4 COMPETITIVE SCENARIO 100
11.4.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016–2019) 100
11.4.2 PRODUCT LAUNCHES & ENHANCEMENTS (2016–2019) 101
11.4.3 EXPANSIONS (2016–2019) 101
11.4.4 ACQUISITIONS (2016–2019) 102

12 COMPANY PROFILES 103
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC. 103
12.2 DANAHER CORPORATION 106
12.3 AGILENT TECHNOLOGIES, INC. 109
12.4 BIO-RAD LABORATORIES, INC. 112
12.5 BRUKER CORPORATION 114
12.6 GENSCRIPT BIOTECH CORPORATION 116
12.7 CODEXIS, INC. 118
12.8 WATERS CORPORATION 120
12.9 NEW ENGLAND BIOLABS, INC. 123
12.10 MERCK KGAA 125
12.11 PERKINELMER, INC. 127
12.12 GE HEALTHCARE 129
12.13 CREATIVE BIOLABS 131
12.14 ENANTIS S.R.O. 132
12.15 PROMEGA CORPORATION 133
12.16 ABZENA, LTD. 134
12.17 PROTEOGENIX 136
12.18 INNOVAGEN AB 137
12.19 PHYNEXUS, INC. (A PART OF BIOTAGE) 138
12.20 TAKARA BIO, INC. 139
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
?

13 APPENDIX 140
13.1 DISCUSSION GUIDE 140
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
13.3 AVAILABLE CUSTOMIZATIONS 145
13.4 RELATED REPORTS 145
13.5 AUTHOR DETAILS 146



List of Figures



FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 23
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 24
FIGURE 4 MARKET SIZE ESTIMATION: PROTEIN ENGINEERING MARKET 25
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 26
FIGURE 6 PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2019 VS. 2024 (USD MILLION) 28
FIGURE 7 PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2019 VS. 2024 29
FIGURE 8 PROTEIN ENGINEERING MARKET SHARE, BY TECHNOLOGY, 2018 29
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN ENGINEERING MARKET 30
FIGURE 10 INCREASING INVESTMENTS IN SYNTHETIC BIOLOGY TO DRIVE MARKET GROWTH 31
FIGURE 11 INSTRUMENTS HELD THE LARGEST SHARE OF THE PROTEIN ENGINEERING MARKET IN THE ASIA PACIFIC 32
FIGURE 12 BIOPHARMACEUTICAL COMPANIES DOMINATED THE PROTEIN ENGINEERING MARKET IN 2018 33
FIGURE 13 APAC TO WITNESS THE HIGHEST GROWTH IN THE PROTEIN ENGINEERING MARKET DURING THE FORECAST PERIOD 33
FIGURE 14 PROTEIN ENGINEERING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 34
FIGURE 15 PROTEIN ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71
FIGURE 16 NORTH AMERICA: PROTEIN ENGINEERING MARKET SNAPSHOT 72
FIGURE 17 ASIA PACIFIC: PROTEIN ENGINEERING MARKET SNAPSHOT 86
FIGURE 18 RANK OF COMPANIES IN THE PROTEIN ENGINEERING MARKET, 2018 97
FIGURE 19 VENDOR COMPARISON MATRIX: PROTEIN ENGINEERING MARKET (2018) 99
FIGURE 20 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. (2018) 103
FIGURE 21 COMPANY SNAPSHOT: DANAHER CORPORATION (2018) 106
FIGURE 22 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC. (2019) 109
FIGURE 23 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2018) 112
FIGURE 24 COMPANY SNAPSHOT: BRUKER CORPORATION (2018) 114
FIGURE 25 COMPANY SNAPSHOT: GENSCRIPT BIOTECH CORPORATION (2018) 116
FIGURE 26 COMPANY SNAPSHOT: CODEXIS, INC. (2018) 118
FIGURE 27 COMPANY SNAPSHOT: WATERS CORPORATION (2018) 120
FIGURE 28 COMPANY SNAPSHOT: MERCK KGAA (2018) 125
FIGURE 29 COMPANY SNAPSHOT: PERKINELMER, INC. (2018) 127
FIGURE 30 COMPANY SNAPSHOT: GE HEALTHCARE (2018) 129
FIGURE 31 COMPANY SNAPSHOT: ABZENA, LTD. (2018) 134
FIGURE 32 COMPANY SNAPSHOT: TAKARA BIO, INC. (2019) 139

 

List of Tables



TABLE 1 PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 38
TABLE 2 PROTEIN ENGINEERING INSTRUMENTS MARKET, BY REGION 2017–2024 (USD MILLION) 38
TABLE 3 NORTH AMERICA: PROTEIN ENGINEERING INSTRUMENTS MARKET BY COUNTRY, 2017–2024 (USD MILLION) 39
TABLE 4 EUROPE: PROTEIN ENGINEERING INSTRUMENTS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 39
TABLE 5 APAC: PROTEIN ENGINEERING INSTRUMENTS MARKET, BY COUNTRY 2017–2024 (USD MILLION) 39
TABLE 6 PROTEIN ENGINEERING CONSUMABLES MARKET, BY REGION 2017–2024 (USD MILLION) 40
TABLE 7 NORTH AMERICA: PROTEIN ENGINEERING CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 40
TABLE 8 EUROPE: PROTEIN ENGINEERING CONSUMABLES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 40
TABLE 9 APAC: PROTEIN ENGINEERING CONSUMABLES MARKET, BY COUNTRY 2017–2024 (USD MILLION) 41
TABLE 10 PROTEIN ENGINEERING SOFTWARE & SERVICES MARKET, BY REGION 2017–2024 (USD MILLION) 41
TABLE 11 NORTH AMERICA: PROTEIN ENGINEERING SOFTWARE & SERVICES MARKET BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 12 EUROPE: PROTEIN ENGINEERING SOFTWARE & SERVICES MARKET BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 13 APAC: PROTEIN ENGINEERING SOFTWARE & SERVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 42
TABLE 14 PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2017–2024 (USD MILLION) 44
TABLE 15 PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 16 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 17 EUROPE: PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 18 APAC: PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES BY COUNTRY, 2017–2024 (USD MILLION) 45
TABLE 19 PROTEIN ENGINEERING MARKET FOR INSULIN, BY REGION 2017–2024 (USD MILLION) 46
TABLE 20 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR INSULIN BY COUNTRY, 2017–2024 (USD MILLION) 46
TABLE 21 EUROPE: PROTEIN ENGINEERING MARKET FOR INSULIN, BY COUNTRY 2017–2024 (USD MILLION) 46
TABLE 22 APAC: PROTEIN ENGINEERING MARKET FOR INSULIN, BY COUNTRY 2017–2024 (USD MILLION) 47
TABLE 23 PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETINS, BY REGION 2017–2024 (USD MILLION) 47
TABLE 24 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETINS BY COUNTRY, 2017–2024 (USD MILLION) 48
TABLE 25 EUROPE: PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETINS, BY COUNTRY, 2017–2024 (USD MILLION) 48
TABLE 26 APAC: PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETINS, BY COUNTRY, 2017–2024 (USD MILLION) 48
TABLE 27 PROTEIN ENGINEERING MARKET FOR INTERFERONS, BY REGION 2017–2024 (USD MILLION) 49
TABLE 28 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR INTERFERONS BY COUNTRY, 2017–2024 (USD MILLION) 49
TABLE 29 EUROPE: PROTEIN ENGINEERING MARKET FOR INTERFERONS, BY COUNTRY, 2017–2024 (USD MILLION) 49
TABLE 30 APAC: PROTEIN ENGINEERING MARKET FOR INTERFERONS, BY COUNTRY 2017–2024 (USD MILLION) 50
TABLE 31 PROTEIN ENGINEERING MARKET FOR VACCINES, BY REGION 2017–2024 (USD MILLION) 50
TABLE 32 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR VACCINES, BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 33 EUROPE: PROTEIN ENGINEERING MARKET FOR VACCINES BY COUNTRY 2017–2024 (USD MILLION) 51
TABLE 34 APAC: PROTEIN ENGINEERING MARKET FOR VACCINES, BY COUNTRY 2017–2024 (USD MILLION) 51
TABLE 35 PROTEIN ENGINEERING MARKET FOR COLONY-STIMULATING FACTORS BY REGION, 2017–2024 (USD MILLION) 52
TABLE 36 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR COLONY-STIMULATING FACTORS, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 37 EUROPE: PROTEIN ENGINEERING MARKET FOR COLONY-STIMULATING FACTORS, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 38 APAC: PROTEIN ENGINEERING MARKET FOR COLONY-STIMULATING FACTORS BY COUNTRY, 2017–2024 (USD MILLION) 53
TABLE 39 PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES, BY REGION 2017–2024 (USD MILLION) 53
TABLE 40 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 41 EUROPE: PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 42 APAC: PROTEIN ENGINEERING MARKET FOR GROWTH HORMONES BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 43 PROTEIN ENGINEERING MARKET FOR COAGULATION FACTORS, BY REGION 2017–2024 (USD MILLION) 55
TABLE 44 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR COAGULATION FACTORS, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 45 EUROPE: PROTEIN ENGINEERING MARKET FOR COAGULATION FACTORS BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 46 APAC: PROTEIN ENGINEERING MARKET FOR COAGULATION FACTORS BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 47 PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY REGION 2017–2024 (USD MILLION) 56
TABLE 48 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 49 EUROPE: PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 50 APAC: PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 51 PROTEIN ENGINEERING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 59
TABLE 52 PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 53 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 54 EUROPE: PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 55 APAC: PROTEIN ENGINEERING MARKET FOR RATIONAL PROTEIN DESIGN BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 56 PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 57 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN, BY COUNTRY, 2017–2024 (USD MILLION) 61
TABLE 58 EUROPE: PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 59 APAC: PROTEIN ENGINEERING MARKET FOR IRRATIONAL PROTEIN DESIGN BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 60 PROTEIN ENGINEERING MARKET, BY END USER, 2017–2024 (USD MILLION) 64
TABLE 61 PROTEIN ENGINEERING MARKET FOR BIOPHARMACEUTICAL COMPANIES BY REGION, 2017–2024 (USD MILLION) 64
TABLE 62 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 63 EUROPE: PROTEIN ENGINEERING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 64 APAC: PROTEIN ENGINEERING MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 65 PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BY REGION, 2017–2024 (USD MILLION) 66
TABLE 66 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 67 EUROPE: PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 68 APAC: PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 69 PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES BY REGION, 2017–2024 (USD MILLION) 68
TABLE 70 NORTH AMERICA: PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 71 EUROPE: PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 72 APAC: PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES BY COUNTRY, 2017–2024 (USD MILLION) 69
TABLE 73 PROTEIN ENGINEERING MARKET, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 74 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY COUNTRY 2017–2024 (USD MILLION) 73
TABLE 75 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 73
TABLE 76 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 73
TABLE 77 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 74
TABLE 78 NORTH AMERICA: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 74
TABLE 79 US: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 75
TABLE 80 US: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 75
TABLE 81 US: PROTEIN ENGINEERING MARKET, BY END USER, 2017–2024 (USD MILLION) 75
TABLE 82 US: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 76
TABLE 83 CANADA: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 76
TABLE 84 CANADA: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 77
TABLE 85 CANADA: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 77
TABLE 86 CANADA: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 77
TABLE 87 EUROPE: PROTEIN ENGINEERING MARKET, BY COUNTRY 2017–2024 (USD MILLION) 78
TABLE 88 EUROPE: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 78
TABLE 89 EUROPE: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 78
TABLE 90 EUROPE: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 79
TABLE 91 EUROPE: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 79
TABLE 92 GERMANY: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 80
TABLE 93 GERMANY: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 80
TABLE 94 GERMANY: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 80
TABLE 95 GERMANY: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 81
TABLE 96 UK: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 81
TABLE 97 UK: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 82
TABLE 98 UK: PROTEIN ENGINEERING MARKET, BY END USER, 2017–2024 (USD MILLION) 82
TABLE 99 UK: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 82
TABLE 100 FRANCE: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 83
TABLE 101 FRANCE: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 83
TABLE 102 FRANCE: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 83
TABLE 103 FRANCE: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 84
TABLE 104 ROE: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 84
TABLE 105 ROE: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 84
TABLE 106 ROE: PROTEIN ENGINEERING MARKET, BY END USER, 2017–2024 (USD MILLION) 85
TABLE 107 ROE: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 85
TABLE 108 APAC: PROTEIN ENGINEERING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 87
TABLE 109 APAC: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 87
TABLE 110 APAC: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 87
TABLE 111 APAC: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 88
TABLE 112 APAC: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 88
TABLE 113 JAPAN: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 89
TABLE 114 JAPAN: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 89
TABLE 115 JAPAN: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 89
TABLE 116 JAPAN: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 90
TABLE 117 CHINA: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 90
TABLE 118 CHINA: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 91
TABLE 119 CHINA: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 91
TABLE 120 CHINA: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 91
TABLE 121 INDIA: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 92
TABLE 122 INDIA: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 92
TABLE 123 INDIA: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 92
TABLE 124 INDIA: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 93
TABLE 125 ROAPAC: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 93
TABLE 126 ROAPAC: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 94
TABLE 127 ROAPAC: PROTEIN ENGINEERING MARKET, BY END USER 2017–2024 (USD MILLION) 94
TABLE 128 ROAPAC: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 94
TABLE 129 ROW: PROTEIN ENGINEERING MARKET, BY PRODUCT & SERVICE 2017–2024 (USD MILLION) 95
TABLE 130 ROW: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY 2017–2024 (USD MILLION) 95
TABLE 131 ROW: PROTEIN ENGINEERING MARKET, BY END USER, 2017–2024 (USD MILLION) 95
TABLE 132 ROW: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE 2017–2024 (USD MILLION) 96